The Street's response to hospital stocks has largely been positive since April this year. Barring a few big names such as Apollo Hospitals, and Fortis Healthcare, most stocks have outperformed the markets.
Aster DM Healthcare, Shalby, and Max Healthcare have been the top performers during this period, having gained up to 26 per cent as compared to a 0.9 and 2 per cent slide in the BSE Sensex, and BSE Healthcare indices, respectively.
Going ahead, analysts expect the momentum to continue as the prospects remain fairly upbeat. The sector, they say, is a favourable bet over the medium to long term as most players are yet to hit their peak utilisation levels.
"Hospital players have been in a consolidation phase for the past few years, and the benefit started reflecting only in the last two years. However, most companies have still not reached their optimum utilisation levels, with some still operating below pre-Covid-19 levels. International patient inflow has also not fully recovered. These factors will drive growth in the medium term," says Param Desai, Research Analyst at Prabhudas Lilladher.
هذه القصة مأخوذة من طبعة October 05, 2022 من Business Standard.
ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 8500 مجلة وصحيفة.
بالفعل مشترك ? تسجيل الدخول
هذه القصة مأخوذة من طبعة October 05, 2022 من Business Standard.
ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 8500 مجلة وصحيفة.
بالفعل مشترك? تسجيل الدخول
Dividend spurs hope for 1 trn cut in govt borrowing
The RBI approved a dividend of 2.11 trillion for the central government for 2023-24, marking an increase of roughly 141 per cent from 2022-23 (FY23). In addition, the contingency risk buffer has been raised to 6.5 per cent from the previous 6 per cent.
Markets and polls: The Bernstein playbook
With the Lok Sabha election results less than two weeks away, the markets are sitting pretty with the benchmark Nifty and the Sensex closing at record highs.
Adani Group mcap rises to ₹17.5 trillion
Highest since January 24, 2023, when Hindenburg released its report against the group
Weak Q4 may be rare bitter pill for Sun Pharma
DEVANGSHU DATTA Sun Pharmaceutical Industries reported a 34 per cent year-onyear (Y-o-Y) jump in net profit to ₹2,654.6 crore in Q4FY24.
Jio Financial seeks shareholder nod to increase FPI legroom
Jio Financial Services has sought shareholders' approval to raise foreign investments (including foreign portfolio investments), amounting up to 49 per cent of the equity share capital.
BSE calls off merger of GIFT City unit with NSE
Talks fail over disagreements regarding merger
Sebi proposes measures to ease ESG disclosures by listed companies
The Securities and Exchange Board of India (Sebi) has proposed measures to ease environmental, social and governance or ESG-related disclosures by listed companies and their value chain partners.
IPL to boxing, IIT Madras packs a punch with Al
Royal Challengers Bengaluru (RCB) are out of the Indian Premier League (IPL) this season, but they have made a splash by actively incorporating artificial intelligence (AI) and data analytics to enhance player performance developed by the Indian Institute of Technology Madras (IIT Madras).
Limits of the global gold rush
Driven by increased demand, international gold prices are at record highs, surging over 30 per cent in the past two years.
The white man's burden on global tourism
On her travels to Konya in central Turkey, a carpet seller she has befriended asks Shahnaz Habib where she's from.